*Applies to a deviation of less than 1%; not applicable for per-share numbers.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for Trupanion, Inc. is $38.00, about 54.2% above its August 4 closing price of $24.65
The stock recently traded at 40 times the next 12-month earnings vs. a P/E of 43 three months ago
TRUP•
